Search

Your search keyword '"Billaud E"' showing total 491 results

Search Constraints

Start Over You searched for: Author "Billaud E" Remove constraint Author: "Billaud E"
491 results on '"Billaud E"'

Search Results

1. Electron Paramagnetic Resonance spectroscopy of a scheelite crystal using microwave photon counting

3. Spatially-resolved decoherence of donor spins in silicon strained by a metallic electrode

4. Spatially Resolved Decoherence of Donor Spins in Silicon Strained by a Metallic Electrode

10. Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus‐co‐infected patients (ANRS CO13‐HEPAVIH)

13. Depressive symptoms after hepatitis C cure and socio-behavioral correlates in aging people living with HIV (ANRS CO13 HEPAVIH)

16. No relationship between late HIV diagnosis and social deprivation in newly diagnosed patients in France

17. Efficacy, safety and patient‐reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor‐experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study)

21. Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress?

22. Post‐HCV cure self‐reported changes in physical activity, eating behaviours, and fatigue in people living with HIV (ANRS CO13 HEPAVIH)

23. No increased risk of Kaposi sarcoma relapse in patients with controlled HIV‐1 infection after switching protease inhibitor‐based antiretroviral therapy

24. Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?

25. Efficacy and safety of dolutegravir and rilpivirine dual therapy as a simplification strategy: a cohort study

26. Levels and determinants of breast and cervical cancer screening uptake in HIV‐infected women compared with the general population in France

28. Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial

29. No barrier to care, yet disparities in the HIV care continuum in France: a nationwide population study

30. Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission

35. Microelimination or Not? The Changing Epidemiology of Human Immunodeficiency Virus-Hepatitis C Virus Coinfection in France 2012-2018

36. Reaching the Second and Third Joint United Nations Programme on HIV/AIDS 90-90-90 Targets Is Accompanied by a Dramatic Reduction in Primary Human Immunodeficiency Virus (HIV) Infection and in Recent HIV Infections in a Large French Nationwide HIV Cohort

37. Kaposi sarcoma among people living with HIV in the French DAT'AIDS cohort between 2010 and 2015

38. Multimorbidity in Elderly Persons According to the Year of Diagnosis of Human Immunodeficiency Virus Infection: A Cross-sectional Dat’AIDS Cohort Study

39. Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death

40. Role and evolution of viral tropism in patients with advanced HIV disease receiving intensified initial regimen in the ANRS 130 APOLLO trial

44. Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavir

45. Extensive cutaneous and muscular mucormycosis complicating insulin pump treatment

46. Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH)

Catalog

Books, media, physical & digital resources